Important regulatory news last week included Otsuka gaining accelerated Food and Drug Administration approval for its Voyxact (sibeprenlimab) for immunoglobulin A nephrology, India’s Sun Pharma for ...
International understanding of China’s arrival as a leading player on the world stage as an innovator of new medicines is now ...
India’s pharmaceutical sector is witnessing global majors deepening their footprint in advanced therapies. The Central Drugs ...
French vaccine developer Valneva (Nasdaq: VALN) plans to close its Nantes site and consolidate all French activities in Lyon ...
Zhongmou Therapeutics, a Chinese genomic medicine company focused on restoring vision through gene and optogenetic therapies, ...
Cantor Fitzgerald issued a note showing that this week saw a broad-based bounce back in GLP-1 prescription activity after ...
The European Association of Hospital Pharmacists (EAHP) released the results of its new Shortages Survey, assessing and ...
NEC Corporation and Otsuka subsidiary Taiho Pharmaceutical have signed a three-party joint research agreement aimed at ...
Australian biotech Cartherics has appointed Dr Ian Nisbet as chief executive (CEO) as part of a planned leadership transition ...
US biotech Vanda Pharmaceuticals (Nasdaq: VNDA) says the American medicines regulator has extended its expedited re-review of ...
US drugmaker AbbVie has announced two updates for Canadians living with ulcerative colitis (UC) in relation to its drug ...
Eisai (TYO: 4523) has submitted a new drug application in Japan for a subcutaneous autoinjector version of Leqembi (lecanemab ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback